Thus, the association between ADK and cell proliferation in the process of development, correlation of changes in the expression of this enzyme in the tumor tissue, as well as association of epigenetic changes that are observed during cancer, make ADK, in particular, ADK-L, a promising therapeutic target. Here, ADK is linked to cancer.